Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Schulz

Showing results (301-310 of 309) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 309 results.
Cardiovascular Research|June 3, 2020
Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the HeartCinzia Perrino, Péter Ferdinandy, Hans E Bøtker, et al.
Basic Research in Cardiology|August 19, 2018
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotectionHans Erik Bøtker, Derek Hausenloy, Ioanna Andreadou, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
Circulation|January 20, 2018
Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor GrowthMingchuan Li, Valentina Sala, Maria Chiara De Santis, et al.
American Heart Journal|September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trialAntoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
Basic Research in Cardiology|October 16, 2016
From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"Hector A Cabrera-Fuentes, Julian Aragones, Jürgen Bernhagen, et al.
Cardiovascular Research|January 9, 2022
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the HeartJolanda van der Velden, Folkert W Asselbergs, Jeroen Bakkers, et al.
Redox Biology|June 4, 2017
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)Javier Egea, Isabel Fabregat, Yves M Frapart, et al.
Pageof 31

Showing results (301-310 of 309) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 309 results.
Cardiovascular Research|June 3, 2020
Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the HeartCinzia Perrino, Péter Ferdinandy, Hans E Bøtker, et al.
Basic Research in Cardiology|August 19, 2018
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotectionHans Erik Bøtker, Derek Hausenloy, Ioanna Andreadou, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
Circulation|January 20, 2018
Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor GrowthMingchuan Li, Valentina Sala, Maria Chiara De Santis, et al.
American Heart Journal|September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trialAntoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
Basic Research in Cardiology|October 16, 2016
From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"Hector A Cabrera-Fuentes, Julian Aragones, Jürgen Bernhagen, et al.
Cardiovascular Research|January 9, 2022
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the HeartJolanda van der Velden, Folkert W Asselbergs, Jeroen Bakkers, et al.
Redox Biology|June 4, 2017
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)Javier Egea, Isabel Fabregat, Yves M Frapart, et al.
Pageof 31